135 related articles for article (PubMed ID: 19886753)
1. Compound 48/80 causes oxidative stress in the adrenal gland of rats through mast cell degranulation.
Kaida S; Ohta Y; Imai Y; Ohashi K; Kawanishi M
Free Radic Res; 2010 Feb; 44(2):171-80. PubMed ID: 19886753
[TBL] [Abstract][Full Text] [Related]
2. Repeated recurrence of gastric mucosal lesions in rats after a single treatment with compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():139-48. PubMed ID: 20388957
[TBL] [Abstract][Full Text] [Related]
3. Plaunotol prevents the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Ohta Y; Kamiya Y; Imai Y; Arisawa T; Nakano H
Pharmacology; 2005 Jul; 74(4):182-92. PubMed ID: 15855831
[TBL] [Abstract][Full Text] [Related]
4. Activation of connective tissue-type and mucosal-type mast cells in compound 48/80-induced airway response.
Liu S; Hiedayati N; Shudou M; Maeyama K
Eur J Pharmacol; 2006 Jan; 530(1-2):128-35. PubMed ID: 16360144
[TBL] [Abstract][Full Text] [Related]
5. Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone.
Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
Biol Pharm Bull; 2005 Aug; 28(8):1424-30. PubMed ID: 16079487
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral vitamin E administration on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
Biol Pharm Bull; 2006 Apr; 29(4):675-83. PubMed ID: 16595898
[TBL] [Abstract][Full Text] [Related]
7. Differential effects on sympathetic neurotransmission of mast cell degranulation by compound 48/80 or antigen in the rat isolated perfused heart.
Ries P; Fuder H
Methods Find Exp Clin Pharmacol; 1994; 16(6):419-35. PubMed ID: 7530791
[TBL] [Abstract][Full Text] [Related]
8. Effect of compound 48/80 on mast cells and histamine levels in rat brain and on corticosterone secretion.
Bugajski AJ; Chłap Z; Gadek-Michalska A; Borycz J; Bugajski J
Inflamm Res; 1997 Mar; 46 Suppl 1():S47-8. PubMed ID: 9098759
[No Abstract] [Full Text] [Related]
9. Preventive effect of Shigyaku-san on progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Ohta Y; Kobayashi T; Hayashi T; Inui K; Yoshino J; Nakazawa S
Phytother Res; 2006 Apr; 20(4):256-62. PubMed ID: 16557606
[TBL] [Abstract][Full Text] [Related]
10. Effect of compound 48/80 on the thalamic mast cells, serotonin level and corticosterone secretion in rats.
Bugajski J; Bugajski AJ; Chłap Z; Borycz J
J Physiol Pharmacol; 1994 Dec; 45(4):583-92. PubMed ID: 7727800
[TBL] [Abstract][Full Text] [Related]
11. Effect of compound 48/80 on mast cells and biogenic amine levels in brain structures and on corticosterone secretion.
Bugajski AJ; Chłap Z; Bugajski J; Borycz J
J Physiol Pharmacol; 1995 Dec; 46(4):513-22. PubMed ID: 8770794
[TBL] [Abstract][Full Text] [Related]
12. Mast cell degranulation and parenchymal cell injury in the rat mesentery.
Costa JJ; Harris AG; Delano FA; Zweifach BW; Schmid-Schönbein GW
Microcirculation; 1999 Sep; 6(3):237-44. PubMed ID: 10501097
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of brain mast cells by compound 48/80, a histamine liberator, evokes renin and vasopressin release in dogs.
Matsumoto I; Inoue Y; Shimada T; Matsunaga T; Aikawa T
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R689-98. PubMed ID: 18184767
[TBL] [Abstract][Full Text] [Related]
14. Novel anti-ulcer alpha,beta-unsaturated lactones inhibit compound 48/80-induced mast cell degranulation.
Penissi AB; Vera ME; Mariani ML; Rudolph MI; Ceñal JP; de Rosas JC; Fogal TH; Tonn CE; Favier LS; Giordano OS; Piezzi RS
Eur J Pharmacol; 2009 Jun; 612(1-3):122-30. PubMed ID: 19344708
[TBL] [Abstract][Full Text] [Related]
15. Role of endogenous serotonin and histamine in the pathogenesis of gastric mucosal lesions in unanaesthetised rats with a single treatment of compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Ishiguro I
Pharmacol Res; 1999 Apr; 39(4):261-7. PubMed ID: 10208755
[TBL] [Abstract][Full Text] [Related]
16. Water-immersion restraint stress disrupts nonenzymatic antioxidant defense systems through rapid and continuous ascorbic acid depletion in the adrenal gland of rats.
Ohta Y; Yashiro K; Kaida S; Imai Y; Ohashi K; Kitagawa A
Cell Biochem Funct; 2013 Apr; 31(3):254-62. PubMed ID: 22987339
[TBL] [Abstract][Full Text] [Related]
17. Effect of brain mast cells degranulation on the corticosterone response to stimulation of central opioid receptors in rats.
Turoń M; Chłap Z; Gadek-Michalska A; Bugajski J; Połczyńska-Konior G
Arch Int Pharmacodyn Ther; 1991; 313():151-60. PubMed ID: 1667847
[TBL] [Abstract][Full Text] [Related]
18. Degranulation of mast cells located in median eminence in response to compound 48/80 evokes adrenocortical secretion via histamine and CRF in dogs.
Matsumoto I; Inoue Y; Tsuchiya K; Shimada T; Aikawa T
Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R969-80. PubMed ID: 15231494
[TBL] [Abstract][Full Text] [Related]
19. Relationship between changes of active oxygen metabolism and blood flow and formation, progression, and recovery of lesions is gastric mucosa of rats with a single treatment of compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Nishida K; Ishiguro I
Dig Dis Sci; 1997 Jun; 42(6):1221-32. PubMed ID: 9201088
[TBL] [Abstract][Full Text] [Related]
20. Evidence for involvement of mast cell degranulation and subsequent stimulation of histamine H1 and H2 receptors in radiographic contrast media-increased vascular permeability in rats.
Goromaru T; Sendo T; Itoh Y; Sakai N; Teshima D; Oishi R
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):605-12. PubMed ID: 12444503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
